Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoinositide-interacting regulator of transient receptor potential channels (PIRT) is a small transmembrane regulatory protein highly expressed in peripheral sensory neurons, where it acts as a key component of the TRPV1 complex. PIRT binds various phosphoinositides—most notably phosphatidylinositol 4,5-bisphosphate (PIP2)—and positively regulates the activity of TRPV1, a critical ion channel for the detection of noxious heat and capsaicin, thereby modulating pain signaling in sensory neurons. It also binds and modulates other transient receptor potential channels such as TRPM8 (cold sensor), with species-dependent effects: for example, human PIRT attenuates human TRPM8 activity while mouse PIRT enhances mouse TRPM8 activity[1][2][3][5]. PIRT exerts its regulatory effects through direct physical interaction with the S1-S4 (sensing, ligand-binding) domain of channel proteins and with PIP2, and acts as a molecular bridge facilitating the lipid modulation of ion channels crucial for pain and thermal sensation[1][2]. Loss of PIRT leads to decreased heat and capsaicin sensitivity in mouse models, underlining its role in nociceptive pathways[2][3]. PIRT is not a classical drug target (e.g., receptor or enzyme), but its central role in ion channel modulation makes it of emerging interest in understanding and potentially modifying pain states[2][3][5].
Allosteric modulation of TRPV1 and TRPM8 channels via phosphoinositide binding; Positive regulation of ion channel function (e.g., enhancing TRPV1 activity in the presence of capsaicin or noxious heat)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide-interacting regulator of transient receptor potential channels (PIRT).